Publication & Citation Trends
Publications
0 total
Acute Febrile Neutrophilic Dermatosis (Sweet Syndrome) in Acute Myeloid Leukemia Patients: A 28-Year Institutional Experience
Cited by 4
Semantic Scholar
Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer OA
Cited by 3
Semantic Scholar
Dermatologic Infections in Cancer Patients Treated with Checkpoint Inhibitors. OA
Cited by 7
Semantic Scholar
Comparison of checkpoint inhibitor treatment-related cutaneous adverse events in racial and ethnic minority and Caucasian cohorts at Memorial Sloan Kettering Cancer Center.
Cited by 1
Semantic Scholar
Suggested methodology for longitudinal evaluation of nevi based on clinical images OA
Cited by 5
Semantic Scholar
CME Part II: Immune checkpoint inhibitor-related dermatologic adverse events. OA
Cited by 310
Semantic Scholar
CME Part I: Immune checkpoint inhibitors to treat cutaneous malignancies. OA
Cited by 81
Semantic Scholar
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer OA
Cited by 34
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(7)
Chemotherapy-related skin toxicity
(6)
Colorectal Cancer Treatments and Studies
(5)
Cutaneous Melanoma Detection and Management
(4)
Nonmelanoma Skin Cancer Studies
(4)
Affiliations
Memorial Sloan Kettering Cancer Center
SUNY Upstate Medical University
Stony Brook University Hospital
Faculty of 1000 (United States)
Columbia University